FIJYX Mutual Fund (Fidelity Advisor Biotechnology Fund Class Z) is managed by Fidelity Investments (US) with $147.5M in net assets. FIJYX expense ratio is 0.58%, holding 84 positions across sectors including Health Care, Financials, Unknown. Inception date: 2018-10-02.

FIJYX performance shows a YTD return of 4.41%. The 1-year return is 44.31% and the 5-year return is 8.50%. FIJYX dividend yield stands at 1.16%, paid annually.

FIJYX top holdings include Abbvie Inc (16.6%), Alnylam Pharmace (7.7%), Gilead Sciences Inc (5.5%), Argenx Se Spon Adr Each Rep 1 Ord Shs (4.7%), Fidelity Securities Lending Cash Central Fund (4.3%). View all FIJYX holdings, sector breakdown, or dividend history.

FIJYX can be compared against other funds using the overlap calculator or side-by-side comparison tool. FIJYX alternatives are available via the screener, along with tax-loss harvesting opportunities.